In the last 12 months, insiders at Aura Biosciences, Inc. ($AURA) filed 111 transactions with the SEC: 4 open-market purchases totaling $343,000 and 31 sales totaling $41,480,149. Net insider sentiment: net selling.
Aura Biosciences, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Matrix Capital Management Company, LP (TenPercentOwner) — 1 transaction totaling $39,044,987
- de los Pinos Elisabet (See Remarks) — 21 transactions totaling $1,397,569
- Feder Julie B (Chief Financial Officer) — 10 transactions totaling $439,414
- Hopkins Janet Jill (Chief Medical Officer) — 10 transactions totaling $326,262
- Gibney Anthony S (See Remarks) — 7 transactions totaling $252,823
View all SEC Filings for Aura Biosciences, Inc. (AURA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2026 | Holles Natalie C. | See Remarks | A | Common Stock | 600118 | $0.00 | 600,118.0000 | 65,936,672 | 9999.99% | 0.91% |
| May 19, 2026 | Holles Natalie C. | See Remarks | A | Common Stock | 553844 | $0.00 | 1,153,962.0000 | 65,936,672 | 92.29% | 0.84% |
| May 19, 2026 | Holles Natalie C. | See Remarks | A | Stock Option (Right to Buy) | 2169103 | $0.00 | 2,169,103.0000 | 65,936,672 | 9999.99% | 3.29% |
| May 7, 2026 | Matrix Capital Management Company, LP | TenPercentOwner | S | Common Stock, par value $0.00001 per share (Common Stock) | 6922870 | $5.64 | 0.0000 | 65,936,672 | 100.00% | 10.50% |
| April 16, 2026 | Kilroy Conor | See Remarks | S | Common Stock | 11738 | $7.02 | 217,835.0000 | 65,936,672 | 5.11% | 0.02% |
| March 2, 2026 | Gibney Anthony S | See Remarks | A | Stock Option (Right to Buy) | 128755 | $0.00 | 128,755.0000 | 65,936,672 | 9999.99% | 0.20% |
| March 2, 2026 | Gibney Anthony S | See Remarks | A | Common Stock | 71245 | $0.00 | 278,178.0000 | 65,936,672 | 34.43% | 0.11% |
| March 2, 2026 | Kilroy Conor | See Remarks | A | Stock Option (Right to Buy) | 112661 | $0.00 | 112,661.0000 | 65,936,672 | 9999.99% | 0.17% |
| March 2, 2026 | Kilroy Conor | See Remarks | A | Common Stock | 62339 | $0.00 | 229,573.0000 | 65,936,672 | 37.28% | 0.09% |
| March 2, 2026 | Elazzouzi Amy | Senior Vice President, Finance | A | Stock Option (Right to Buy) | 80472 | $0.00 | 80,472.0000 | 65,936,672 | 9999.99% | 0.12% |
| March 2, 2026 | Elazzouzi Amy | Senior Vice President, Finance | A | Common Stock | 44528 | $0.00 | 120,060.0000 | 65,936,672 | 58.95% | 0.07% |
| March 2, 2026 | Hopkins Janet Jill | Chief Medical Officer | A | Stock Option (Right to Buy) | 160944 | $0.00 | 160,944.0000 | 65,936,672 | 9999.99% | 0.24% |
| March 2, 2026 | Hopkins Janet Jill | Chief Medical Officer | A | Common Stock | 89056 | $0.00 | 321,340.0000 | 65,936,672 | 38.34% | 0.14% |
| March 2, 2026 | Plavsic Mark | Chief Technology Officer | A | Stock Option (Right to Buy) | 112661 | $0.00 | 112,661.0000 | 65,936,672 | 9999.99% | 0.17% |
| March 2, 2026 | Plavsic Mark | Chief Technology Officer | A | Common Stock | 62339 | $0.00 | 243,736.0000 | 65,936,672 | 34.37% | 0.09% |
| March 2, 2026 | de los Pinos Elisabet | See Remarks | A | Stock Option (Right to Buy) | 249000 | $0.00 | 249,000.0000 | 65,936,672 | 9999.99% | 0.38% |
| March 2, 2026 | de los Pinos Elisabet | See Remarks | A | Common Stock | 166000 | $0.00 | 703,578.0000 | 65,936,672 | 30.88% | 0.25% |
| Feb. 17, 2026 | Hopkins Janet Jill | Chief Medical Officer | S | Common Stock | 20401 | $5.06 | 232,284.0000 | 65,936,672 | 8.07% | 0.03% |
| Feb. 17, 2026 | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 8549 | $5.06 | 75,532.0000 | 65,936,672 | 10.17% | 0.01% |
| Feb. 17, 2026 | de los Pinos Elisabet | See Remarks | S | Common Stock | 47648 | $5.06 | 537,578.0000 | 65,936,672 | 8.14% | 0.07% |
| Feb. 17, 2026 | Kilroy Conor | See Remarks | S | Common Stock | 12079 | $5.05 | 167,234.0000 | 65,936,672 | 6.74% | 0.02% |
| Feb. 17, 2026 | Plavsic Mark | Chief Technology Officer | S | Common Stock | 15890 | $5.05 | 181,397.0000 | 65,936,672 | 8.05% | 0.02% |
| Jan. 20, 2026 | de los Pinos Elisabet | See Remarks | S | Common Stock | 16928 | $4.86 | 585,226.0000 | 65,936,672 | 2.81% | 0.03% |
| Jan. 20, 2026 | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 1581 | $4.86 | 84,081.0000 | 65,936,672 | 1.85% | 0.00% |
| Nov. 17, 2025 | Hopkins Janet Jill | Chief Medical Officer | S | Common Stock | 17109 | $5.42 | 252,685.0000 | 65,936,672 | 6.34% | 0.03% |
| Oct. 29, 2025 | de los Pinos Elisabet | See Remarks | S | Common Stock | 9049 | $6.35 | 602,154.0000 | 65,936,672 | 1.48% | 0.01% |
| Oct. 29, 2025 | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 896 | $6.35 | 85,662.0000 | 65,936,672 | 1.04% | 0.00% |
| Oct. 16, 2025 | Plavsic Mark | Chief Technology Officer | S | Common Stock | 12169 | $6.35 | 197,287.0000 | 65,936,672 | 5.81% | 0.02% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 2554 | $5.07 | 83,935.0000 | 49,650,480 | 3.14% | 0.01% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 1094 | $5.48 | 85,029.0000 | 49,650,480 | 1.30% | 0.00% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 547 | $5.48 | 85,576.0000 | 49,650,480 | 0.64% | 0.00% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 547 | $5.21 | 86,123.0000 | 49,650,480 | 0.64% | 0.00% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 4744 | $2.74 | 90,867.0000 | 49,650,480 | 5.51% | 0.01% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 1094 | $3.16 | 91,961.0000 | 49,650,480 | 1.20% | 0.00% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Common Stock | 2319 | $4.25 | 94,280.0000 | 49,650,480 | 2.52% | 0.00% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 7722 | $6.70 | 86,558.0000 | 49,650,480 | 8.19% | 0.02% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 2554 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.01% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 1094 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.00% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 547 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.00% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 547 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.00% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 4744 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.01% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 1094 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.00% |
| Aug. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | M | Stock Option (Right to Buy) | 2319 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.00% |
| June 17, 2025 | Johnson David Michael | Not found | A | Common Stock | 13000 | $0.00 | 468,839.0000 | 49,650,480 | 2.85% | 0.03% |
| June 17, 2025 | Mattessich Antony C. | Not found | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 49,650,480 | 9999.99% | 0.03% |
| June 17, 2025 | Mattessich Antony C. | Not found | A | Common Stock | 13000 | $0.00 | 23,500.0000 | 49,650,480 | 123.81% | 0.03% |
| June 17, 2025 | Johnson David Michael | Not found | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 49,650,480 | 9999.99% | 0.03% |
| June 17, 2025 | Srivastava Sapna | Not found | A | Common Stock | 13000 | $0.00 | 23,500.0000 | 49,650,480 | 123.81% | 0.03% |
| June 17, 2025 | Srivastava Sapna | Not found | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 49,650,480 | 9999.99% | 0.03% |
| June 2, 2025 | de los Pinos Elisabet | See Remarks | M | Stock Option (Right to Buy) | 10948 | $0.00 | 0.0000 | 49,650,480 | 100.00% | 0.02% |
| June 2, 2025 | de los Pinos Elisabet | See Remarks | F | Common Stock | 9948 | $6.16 | 611,203.0000 | 49,650,480 | 1.60% | 0.02% |
| June 2, 2025 | de los Pinos Elisabet | See Remarks | M | Common Stock | 10948 | $5.07 | 621,151.0000 | 49,650,480 | 1.79% | 0.02% |
| June 2, 2025 | Gibney Anthony S | See Remarks | A | Stock Option (Right to Buy) | 250000 | $0.00 | 250,000.0000 | 49,650,480 | 9999.99% | 0.50% |
| June 2, 2025 | Gibney Anthony S | See Remarks | A | Common Stock | 150000 | $0.00 | 206,933.0000 | 49,650,480 | 263.47% | 0.30% |
| May 16, 2025 | Gibney Anthony S | See Remarks | S | Common Stock | 1519 | $5.15 | 56,933.0000 | 49,650,480 | 2.60% | 0.00% |
| May 16, 2025 | Johnson David Michael | Not found | P | Common Stock | 20000 | $4.90 | 455,839.0000 | 49,650,480 | 4.59% | 0.04% |
| May 16, 2025 | Johnson David Michael | Not found | P | Common Stock Warrants (right to buy) | 5000 | $0.00 | 5,000.0000 | 49,650,480 | 9999.99% | 0.01% |
| May 16, 2025 | Gibney Anthony S | See Remarks | P | Common Stock | 50000 | $4.90 | 58,452.0000 | 49,650,480 | 591.58% | 0.10% |
| May 16, 2025 | Gibney Anthony S | See Remarks | P | Common Stock Warrants (right to buy) | 12500 | $0.00 | 12,500.0000 | 49,650,480 | 9999.99% | 0.03% |
| April 16, 2025 | Kilroy Conor | See Remarks | S | Common Stock | 7162 | $5.49 | 179,313.0000 | 49,650,480 | 3.84% | 0.01% |
| April 16, 2025 | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 897 | $5.49 | 81,381.0000 | 49,650,480 | 1.09% | 0.00% |
| March 31, 2025 | Bitetti Teresa Marie | Not found | A | Common Stock | 21000 | $0.00 | 21,000.0000 | 49,650,480 | 9999.99% | 0.04% |
| March 31, 2025 | Bitetti Teresa Marie | Not found | A | Stock Option (Right to Buy) | 29000 | $0.00 | 29,000.0000 | 49,650,480 | 9999.99% | 0.06% |
| Feb. 18, 2025 | Plavsic Mark | Chief Technology Officer | S | Common Stock | 2151 | $7.75 | 209,456.0000 | 49,650,480 | 1.02% | 0.00% |
| Feb. 18, 2025 | de los Pinos Elisabet | See Remarks | S | Common Stock | 20221 | $7.75 | 610,203.0000 | 49,650,480 | 3.21% | 0.04% |
| Feb. 18, 2025 | Hopkins Janet Jill | Chief Medical Officer | S | Common Stock | 2534 | $7.75 | 269,794.0000 | 49,650,480 | 0.93% | 0.01% |
| Feb. 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | S | Common Stock | 1404 | $7.75 | 82,278.0000 | 49,650,480 | 1.68% | 0.00% |
| Feb. 3, 2025 | Plavsic Mark | Chief Technology Officer | A | Common Stock | 90475 | $0.00 | 211,607.0000 | 49,650,480 | 74.69% | 0.18% |
| Feb. 3, 2025 | Hopkins Janet Jill | Chief Medical Officer | A | Stock Option (Right to Buy) | 79365 | $0.00 | 79,365.0000 | 49,650,480 | 9999.99% | 0.16% |
| Feb. 3, 2025 | Kilroy Conor | See Remarks | A | Common Stock | 90475 | $0.00 | 186,475.0000 | 49,650,480 | 94.24% | 0.18% |
| Feb. 3, 2025 | Kilroy Conor | See Remarks | A | Stock Option (Right to Buy) | 59525 | $0.00 | 59,525.0000 | 49,650,480 | 9999.99% | 0.12% |
| Feb. 3, 2025 | Elazzouzi Amy | Senior Vice President, Finance | A | Common Stock | 45240 | $0.00 | 83,682.0000 | 49,650,480 | 117.68% | 0.09% |
| Feb. 3, 2025 | Elazzouzi Amy | Senior Vice President, Finance | A | Stock Option (Right to Buy) | 29760 | $0.00 | 29,760.0000 | 49,650,480 | 9999.99% | 0.06% |
| Feb. 3, 2025 | Hopkins Janet Jill | Chief Medical Officer | A | Common Stock | 120635 | $0.00 | 272,328.0000 | 49,650,480 | 79.53% | 0.24% |
| Feb. 3, 2025 | de los Pinos Elisabet | See Remarks | A | Stock Option (Right to Buy) | 255680 | $0.00 | 255,680.0000 | 49,650,480 | 9999.99% | 0.51% |
| Feb. 3, 2025 | Plavsic Mark | Chief Technology Officer | A | Stock Option (Right to Buy) | 59525 | $0.00 | 59,525.0000 | 49,650,480 | 9999.99% | 0.12% |
| Feb. 3, 2025 | de los Pinos Elisabet | See Remarks | A | Common Stock | 194320 | $0.00 | 630,424.0000 | 49,650,480 | 44.56% | 0.39% |
| Jan. 21, 2025 | Elazzouzi Amy | Vice President, Finance | S | Common Stock | 1001 | $7.67 | 38,442.0000 | 49,650,480 | 2.54% | 0.00% |
| Jan. 21, 2025 | de los Pinos Elisabet | See Remarks | S | Common Stock | 15955 | $7.67 | 436,104.0000 | 49,650,480 | 3.53% | 0.03% |
| Nov. 18, 2024 | Hopkins Janet Jill | Chief Medical Officer | S | Common Stock | 11822 | $9.36 | 151,693.0000 | 49,663,532 | 7.23% | 0.02% |
| Oct. 29, 2024 | de los Pinos Elisabet | See Remarks | S | Common Stock | 9200 | $10.74 | 452,059.0000 | 49,663,532 | 1.99% | 0.02% |
| Oct. 29, 2024 | Elazzouzi Amy | Vice President, Finance | S | Common Stock | 553 | $10.74 | 39,443.0000 | 49,663,532 | 1.38% | 0.00% |
| Oct. 18, 2024 | Feder Julie B | Chief Financial Officer | M | Common Stock | 5000 | $5.48 | 159,407.0000 | 49,663,532 | 3.24% | 0.01% |
| Oct. 18, 2024 | Feder Julie B | Chief Financial Officer | S | Common Stock | 25131 | $12.03 | 134,276.0000 | 49,663,532 | 15.77% | 0.05% |
| Oct. 18, 2024 | Feder Julie B | Chief Financial Officer | M | Stock Option (Right to Buy) | 17500 | $0.00 | 68,257.0000 | 49,663,532 | 20.41% | 0.04% |
| Oct. 18, 2024 | Feder Julie B | Chief Financial Officer | M | Stock Option (Right to Buy) | 2631 | $0.00 | 32,359.0000 | 49,663,532 | 7.52% | 0.01% |
| Oct. 18, 2024 | Feder Julie B | Chief Financial Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 120,547.0000 | 49,663,532 | 3.98% | 0.01% |
| Oct. 18, 2024 | Feder Julie B | Chief Financial Officer | M | Common Stock | 17500 | $2.74 | 151,776.0000 | 49,663,532 | 13.03% | 0.04% |
| Oct. 18, 2024 | Feder Julie B | Chief Financial Officer | M | Common Stock | 2631 | $4.25 | 154,407.0000 | 49,663,532 | 1.73% | 0.01% |
| Oct. 18, 2024 | de los Pinos Elisabet | See Remarks | M | Stock Option (Right to Buy) | 24992 | $0.00 | 336,171.0000 | 49,663,532 | 6.92% | 0.05% |
| Oct. 18, 2024 | de los Pinos Elisabet | See Remarks | S | Common Stock | 24992 | $12.04 | 461,259.0000 | 49,663,532 | 5.14% | 0.05% |
| Oct. 18, 2024 | de los Pinos Elisabet | See Remarks | M | Common Stock | 24992 | $2.74 | 486,251.0000 | 49,663,532 | 5.42% | 0.05% |
| Oct. 16, 2024 | Plavsic Mark | Chief Technology Officer | S | Common Stock | 7383 | $9.85 | 121,132.0000 | 49,663,532 | 5.74% | 0.01% |
| Sept. 27, 2024 | de los Pinos Elisabet | See Remarks | M | Common Stock | 5474 | $5.76 | 461,259.0000 | 39,620,036 | 1.20% | 0.01% |
| Sept. 27, 2024 | de los Pinos Elisabet | See Remarks | M | Stock Option (Right to Buy) | 5474 | $0.00 | 0.0000 | 39,620,036 | 100.00% | 0.01% |
| June 20, 2024 | Mattessich Antony C. | Not found | A | Common Stock | 10500 | $0.00 | 10,500.0000 | 39,620,036 | 9999.99% | 0.03% |
| June 20, 2024 | Johnson David Michael | Not found | A | Stock Option (Right to Buy) | 14500 | $0.00 | 14,500.0000 | 39,620,036 | 9999.99% | 0.04% |
| June 20, 2024 | Johnson David Michael | Not found | A | Common Stock | 10500 | $0.00 | 435,839.0000 | 39,620,036 | 2.47% | 0.03% |
| June 20, 2024 | Srivastava Sapna | Not found | A | Stock Option (Right to Buy) | 14500 | $0.00 | 14,500.0000 | 39,620,036 | 9999.99% | 0.04% |
| June 20, 2024 | Srivastava Sapna | Not found | A | Common Stock | 10500 | $0.00 | 10,500.0000 | 39,620,036 | 9999.99% | 0.03% |
| June 20, 2024 | Mattessich Antony C. | Not found | A | Stock Option (Right to Buy) | 14500 | $0.00 | 14,500.0000 | 39,620,036 | 9999.99% | 0.04% |
| April 2, 2024 | Kilroy Conor | General Counsel and Secretary | A | Stock Option (Right to Buy) | 144000 | $0.00 | 144,000.0000 | 39,620,036 | 9999.99% | 0.36% |
| April 2, 2024 | Kilroy Conor | General Counsel and Secretary | A | Common Stock | 96000 | $0.00 | 96,000.0000 | 39,620,036 | 9999.99% | 0.24% |
| Feb. 1, 2024 | Hopkins Janet Jill | Chief Medical Officer | A | Stock Option (Right to Buy) | 41485 | $0.00 | 41,485.0000 | 39,620,036 | 9999.99% | 0.10% |
| Feb. 1, 2024 | Feder Julie B | Chief Financial Officer | A | Common Stock | 71285 | $0.00 | 134,276.0000 | 39,620,036 | 113.17% | 0.18% |
| Feb. 1, 2024 | Feder Julie B | Chief Financial Officer | A | Stock Option (Right to Buy) | 103715 | $0.00 | 103,715.0000 | 39,620,036 | 9999.99% | 0.26% |
| Feb. 1, 2024 | de los Pinos Elisabet | See Remarks | A | Common Stock | 162935 | $0.00 | 455,785.0000 | 39,620,036 | 55.64% | 0.41% |
| Feb. 1, 2024 | de los Pinos Elisabet | See Remarks | A | Stock Option (Right to Buy) | 237065 | $0.00 | 237,065.0000 | 39,620,036 | 9999.99% | 0.60% |
| Feb. 1, 2024 | Hopkins Janet Jill | Chief Medical Officer | A | Common Stock | 28515 | $0.00 | 163,515.0000 | 39,620,036 | 21.12% | 0.07% |
| Jan. 23, 2024 | Feder Julie B | Chief Financial Officer | S | Common Stock | 6609 | $7.64 | 62,991.0000 | 39,620,036 | 9.50% | 0.02% |
| Jan. 23, 2024 | de los Pinos Elisabet | See Remarks | S | Common Stock | 15853 | $7.64 | 292,850.0000 | 39,620,036 | 5.14% | 0.04% |